Lidia L. Fonseca

Lidia Fonseca is executive vice president and chief digital and technology officer at Pfizer, where she leads the company’s enterprise-wide digital, artificial intelligence, and technology strategy. Fonseca has played a key role in transforming Pfizer’s operations by integrating advanced digital solutions, automating more than 90 percent of 100 million transactions, and advancing the use of AI—including generative AI—to support innovation in drug discovery, development, manufacturing, and patient engagement. Her leadership contributed to the acceleration of the development and distribution of the COVID-19 vaccine and oral treatment, leveraging digital platforms and data analytics to improve patient outcomes.

Fonseca has also championed initiatives such as the Pfizer Digital Companion suite, which enhances patient and physician engagement, and launched consumer-focused platforms like PfizerForAll to streamline healthcare access. She oversees learning and development and business process excellence, supporting Pfizer’s workforce in digital transformation. Her work has been recognized by Forbes, ALPFA, and Medical, Marketing and Media for her influence as a healthcare innovator and as a prominent Latina business leader.

Fonseca is a public speaker and thought leader who appears at major industry events and in media, discussing the intersection of technology and healthcare. She serves on the boards of Medtronic and other organizations. Her educational background includes an MBA from Rotterdam School of Management and a BA from UC Berkeley. Fonseca’s career reflects a commitment to innovation, talent development, and the effective communication of complex digital strategies, establishing her as a leading voice in healthcare technology and digital transformation.